Epiphora due to primary acquired nasolacrimal duct obstruction describes an entity caused by inflammation without any precipitating cause. Our aim was to assess the efficacy of syringing & probing as the initial symptomatic treatment of epiphora in adults with primary acquired NLDOs. Among 108 eyes from 90 patients, results were calculated after a mean follow up of 7.4 months. 57.4% of the eyes had an outcome of no watering, 15.7% mild watering, 0.9% moderate watering, 25.9% severe watering. The patients satisfaction in terms of symptomatic improvement in epiphora was 73.18%, which is significant. There was a significant difference(Chi–square = 59.772 ,P < 0.001) in the symptom–free period between the no watering and severe watering groups. Syringing &Probing for treating epiphora in adults is highly recommended as an initial treatment for symptomatic relief in primary acquired NLDOs because of its relatively good efficacy, simplicity of procedure and high patient satisfaction without compromising subsequent surgical treatment